HEALTHTRONICS OSSATRON

Generator, Shock-wave, For Pain Relief

FDA Premarket Approval P990086

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

This device is indicated for use for performing extracorporeal shock wave treatment in patients with chronic proximal plantar fasciitis that has failed to respond to conservative treatment. Chronic proximal plantar fasciitis is defined as pain in the area of the insertion of the plantar fascia on the medial calcaneal tuberosity that has persisted for six months or more.

DeviceHEALTHTRONICS OSSATRON
Classification NameGenerator, Shock-wave, For Pain Relief
Generic NameGenerator, Shock-wave, For Pain Relief
ApplicantSANUWAVE, INC.
Date Received1999-12-30
Decision Date2000-10-12
Notice Date2001-06-18
PMAP990086
SupplementS
Product CodeNBN
Docket Number01M-0271
Advisory CommitteeOrthopedic
Expedited ReviewNo
Combination Product No
Applicant Address SANUWAVE, INC. 11680 Great Oaks Way suite 350 alpharetta, GA 30022
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P990086Original Filing
S004 2004-02-09 Normal 180 Day Track No User Fee
S003 2001-11-05 Panel Track
S002 2001-01-12 Real-time Process
S001 2000-10-19 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.